Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Tonix Pharmaceuticals Holding Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
2 insiders, $40.2K in total
Open-market sells
0 filings
Insiders trading
2
Net value
+$40.2K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Tonix Pharmaceuticals Holding Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Tonix Pharmaceuticals Holding Corp.
NameTitleLast reported holdingLast filingFilings, past year
Lederman SethChief Executive Officer11,005IndirectAug 31, 20265
Bagger Richard HDirector1,000Aug 24, 20262
Saenger BradleyChief Financial Officer2,154Jul 9, 20262
Taylor Carolyn E.Director1,833Jun 15, 20262
Stillwell Richard NewcombDirector5,000Jun 9, 20262
Olukotun Adeoye YDirector0May 14, 20261
Grange David LDirector–May 14, 20261
Bell Margaret SmithDirector0May 14, 20261
Treco JamesDirector250May 14, 20261
Hunter James Randolph JrDirector–May 14, 20261
Sullivan Gregory MChief Medical Officer0Feb 26, 20261
Morris Jessica EdgarChief Operating Officer0Feb 26, 20261
Fogarty SiobhanChief Technology Officer–Feb 26, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 31, 2026 (view filing)8:00 AM ETAug 274 daysLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+2.00K$13.79+$27.6K+22.2%11.0K after
Aug 24, 2026 (view filing)8:00 AM ETAug 204 daysBagger Richard HDirectorPPurchaseCommon Stock, par value $0.001+1.00K$12.60+$12.6KNew position1.00K after
Jun 15, 2026 (view filing)Jun 123 daysTaylor Carolyn E.DirectorPPurchaseCommon Stock, $0.001 par value+1.42K$10.55+$14.9K+338.5%1.83K after
Jun 9, 2026 (view filing)Jun 9Same dayLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+5.00K$11.79+$59.0K+124.8%9.01K after
Jun 9, 2026 (view filing)Jun 81 dayStillwell Richard NewcombDirectorPPurchaseCommon Stock, $0.001 par value+5.00K$11.65+$58.3KNew position5.00K after
Apr 1, 2026 (view filing)Mar 311 dayLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+5.00K$12.62+$63.1K+33.3%20.0K after
Mar 18, 2026 (view filing)Mar 18Same dayLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+15.0K$14.89+$223.3K+1,500,000.0%15.0K after
Aug 21, 2025 (view filing)Aug 21Same dayTaylor Carolyn E.DirectorPPurchaseCommon Stock, par value $0.001+418$36.03+$15.1KNew position418 after
Aug 20, 2025 (view filing)Aug 20Same dayTreco JamesDirectorPPurchaseCommon Stock, par value $0.001+250$36.00+$9.00KNew position250 after
May 15, 2025 (view filing)May 15Same dayLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+4.00K$21.55+$86.2K+80,000.0%4.00K after
Jul 1, 2022 (view filing)Jun 292 daysLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+20.0K$1.71+$34.2K+472.3%24.2K after
Mar 28, 2022 (view filing)8:00 AM ETMar 253 daysLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+100.0K$0.245+$24.5K+821.2%112.2K after
Sep 28, 2021 (view filing)Sep 28Same dayLederman SethChief Executive OfficerPPurchaseCommon Stock, $0.001 par value+12.0K$0.61+$7.32K+6,779.7%12.2K after